Table 1 Study population characteristics in terms of knowledge and preferences of GMa
From: Use of generic medicines in Latvia: awareness, opinions and experiences of the population
Sociodemographic characteristics | Are informed about GM | Are not informed about GM | No opinion |
|---|---|---|---|
From total (n = 1005) | 727 (72.3%) | 226 (22.5%) | 52 (5.2%) |
Gender | |||
 Female, n = 528 | 408 (77.3%) | 96 (18.2%) | 24 (4.5%) |
 Male, n = 477 | 319 (66.9%) | 130 (27.3%) | 28 (5.8%) |
Age | |||
 18–24, n = 120 | 71 (59.2%) | 42 (35.0%) | 7 (5.8%) |
 25–34, n = 207 | 155 (74.9%) | 47 (22.7%) | 5 (2.4%) |
 35–44, n = 188 | 141 (75.0%) | 39 (20.7%) | 8 (4.3%) |
 45–54, n = 192 | 130 (67.7%) | 50 (26.0%) | 12 (6.3%) |
  > 55, n = 298 | 229 (76.9%) | 49 (16.4%) | 20 (6.7%) |
Education | |||
 Primary, n = 24 | 14 (58.3%) | 10 (41.7%) | 0 |
 Secondary, n = 339 | 235 (69.3%) | 85 (25.1%) | 19 (5.6%) |
 Higher, n = 642 | 478 (74.5%) | 131 (20.4%) | 33 (5.1%) |
Sociodemographic characteristics | Would prefer/rather prefer GM | Would prefer/rather prefer brand-name medicine | No difference/do not have an opinion |
From total (n = 1005) | 211 (21.0%) | 287 (28.6%) | 507 (50.4%) |
Age | |||
 18–24, n = 120 | 24 (20.2%) | 24 (19.3%) | 72 (60.5%) |
 25–34, n = 207 | 43 (20.8%) | 47 (22.7%) | 117 (56.5%) |
 35–44, n = 188 | 47 (25.0%) | 41 (21.8%) | 100 (53.2%) |
 45–54, n = 192 | 50 (26.0%) | 55 (28.6%) | 87 (45.3%) |
  > 55, n = 298 | 47 (15.7%) | 121 (40.5%) | 130 (43.8%) |
Nationality | |||
 Latvian, n = 586 | 107 (18.3%) | 174 (29.7%) | 305 (52.0%) |
 Other, n = 419 | 104 (24.8%) | 113 (27.0%) | 202 (50.4%) |